A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
Sponsor: Nanfang Hospital, Southern Medical University
Listed as NCT04573283, this observational or N/A phase trial focuses on Metabolic Associated Fatty Liver Disease and remains actively recruiting participants. Sponsored by Nanfang Hospital, Southern Medical University, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Recruiting
-
Dec 2021 — Jul 2023 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nanfang Hospital, Southern Medical University
For direct contact, visit the study record on ClinicalTrials.gov .